Kenneth Beer Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2010
NCT01354743
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Kenneth Beer, M.D.,PA

Active Ingredients

Drugs in Phase 4 Trials (3)

bimatoprost (lumigan) (1 trial)

hyaluronic acid (1 trial)

rimabotulinumtoxinB (Myobloc) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophy (Phase 4)

Hypotrichosis (Phase 4)

Prolapse (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 3